FILE PHOTO: A nurse administers the Oxford-AstraZeneca COVID-19 vaccine to a member of the medical staff at a coronavirus disease (COVID-19) vaccination center in La Baule, France, February 17, 2021. REUTERS/Stephane Mahe/File Photo
(Reuters) - More clinical and real-world data is needed on how well and for how long COVID-19 vaccines are protective before any decisions should be made on offering third or booster doses, Europe's drug regulators said on Wednesday.
Speaking at the first of planned regular fortnightly media briefings on the coronavirus pandemic, the European Medicines Agency's head of biological health threats and vaccines strategy Marco Cavaleri cautioned against making "premature" moves to deploy booster COVID-19 shots.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
